Health Care & Life Sciences » Biotechnology | Vitro Diagnostics Inc.

Vitro Diagnostics Inc. | Balance Sheet

Fiscal year is November-October. All values USD Thousands.
2012
2013
2014
2015
2017
Cash & Short Term Investments
5.30
2.20
2.80
5.30
2.60
Total Accounts Receivable
4.70
5.40
21.60
15.20
40.90
Inventories
26.70
25.20
22.30
28.80
25.00
Other Current Assets
-
0.30
-
-
-
Total Current Assets
36.70
33.20
46.70
49.30
68.50
Net Property, Plant & Equipment
17.00
10.80
41.90
44.10
172.50
Intangible Assets
20.60
18.00
14.80
11.60
22.30
Other Assets
10.90
14.30
2.20
11.20
-
Total Assets
85.20
76.20
105.60
116.10
263.30
ST Debt & Current Portion LT Debt
37.10
614.30
780.00
903.50
71.90
Accounts Payable
68.60
58.60
77.70
69.00
49.90
Other Current Liabilities
1,734.30
1,336.70
1,407.90
1,522.30
-
Total Current Liabilities
1,839.90
2,009.70
2,265.60
2,494.80
121.80
Long-Term Debt
-
-
-
3.20
1,967.40
Other Liabilities
-
-
-
-
1,206.00
Total Liabilities
1,839.90
2,009.70
2,265.60
2,498.00
3,295.20
Common Equity (Total)
1,754.70
1,933.50
2,160.00
2,381.90
3,031.90
Total Shareholders' Equity
1,754.70
1,933.50
2,160.00
2,381.90
3,031.90
Total Equity
1,754.70
1,933.50
2,160.00
2,381.90
3,031.90
Liabilities & Shareholders' Equity
85.20
76.20
105.60
116.10
263.30

About Vitro Diagnostics

View Profile
Address
4621 Technology Drive
Golden Colorado 80403
United States
Employees -
Website http://www.vitrobiopharma.com
Updated 07/08/2019
Vitro Diagnostics, Inc. develops and commercializes adult stem cell technology for applications in stem cell research, drug development and therapeutic products for treatment a vast variety of diseases and conditions. It also offer a series of tools to promote the development of stem cell research and clinical applications focusing on Mesenchymal Stem Cells. The company was founded by James R.